Who Owns Bio-Rad Company?

Who Owns Bio-Rad Laboratories?

Bio-Rad Laboratories is a public company, not a private one. The Schwartz family still holds key voting power through dual-class shares. That gives the founders lasting influence over control and governance.

So, ownership is shared by public investors, but control is not. For a quick look at its market setup, see the Bio-Rad Balanced Scorecard.

Bio-Rad Laboratories was founded in 1952 by David and Alice Schwartz, and that founder family still shapes Bio-Rad ownership today. It is a public company with no parent, but Bio-Rad stock ownership is split between public holders and a family control block tied to Bio-Rad class B shares.

Founder control started early

The Schwartz family helped build Bio-Rad Laboratories from the start. That early role still matters because founder family ownership remains the key control anchor.

Public trading did not end family control

Bio-Rad is publicly traded, so Bio-Rad shareholders include institutions, insiders, and retail holders. Still, Bio-Rad voting shares keep control concentrated.

Two classes drive the structure

Bio-Rad class A shares trade in the market and carry the economic float. Bio-Rad class B shares hold the stronger vote and decide who controls Bio-Rad Laboratories.

Ownership and control are not the same

Bio-Rad institutional ownership can be large, but it mostly affects cash-flow claims, not control. That split is central to Bio-Rad ownership structure and legitimacy questions.

SEC filings can shift, control usually does not

Bio-Rad stockholder information changes each quarter as filings update. The decisive fact stays the same: the Schwartz family block is the main voting lever.

Why founders still matter

For investors asking who owns Bio-Rad, the answer is more than a cap table. Bio-Rad family ownership still defines how the business is governed.

Bio-Rad company ownership details show a simple split: economic ownership is broad, but control is narrow. Large Bio-Rad Laboratories investors may own meaningful amounts of the float, yet the family block tied to Bio-Rad founder family ownership remains the key vote holder. For a related read on the business mix, see Target Market of Bio-Rad.

Who owns Bio-Rad Laboratories today

Bio-Rad ownership is split between public holders and a concentrated control block. The company has no parent, and Bio-Rad major shareholders are shaped by the dual-class setup.

• Founded in 1952 by the Schwartz family
• Publicly traded with no parent company
• Class A shares trade publicly
• Class B shares carry stronger voting power

Bio-Rad SWOT Analysis

• Organized to Save Time on Analysis
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

Bio-Rad Laboratories, Inc. started with founder-led control and still carries that mark today. The shift to public ownership brought outside capital, but the dual-class share setup kept voting power concentrated with the Bio-Rad family, which still shapes Who owns Bio-Rad and Who controls Bio-Rad Laboratories.

Bio-Rad ownership is shaped less by turnover and more by continuity. That matters because buyers in regulated markets often read stable Bio-Rad family ownership as a sign that product quality and scientific standards still sit near the center of the business, even while Bio-Rad shareholders supply most of the liquid capital. Still, the same Bio-Rad ownership breakdown also means public holders have weaker accountability rights than they would in a one-share, one-vote company.

Bio-Rad ownership and public trust

Bio-Rad stock ownership combines public market access with family voting control. That can support brand trust in diagnostics, but it also keeps decision power concentrated.

• Bio-Rad major shareholders include the founder family
• Bio-Rad institutional ownership funds daily trading
• Bio-Rad insider ownership supports continuity
• Bio-Rad largest shareholders hold stronger voting rights

Bio-Rad stockholder information matters because ownership and control are not the same thing here. Bio-Rad shareholders can buy and sell a public stock, but the Bio-Rad voting shares structure gives the family more influence than its economic stake alone would suggest. That is why Is Bio-Rad publicly traded and Who owns Bio-Rad Laboratories can have different answers depending on whether the question is about cash flow rights or voting power.

Bio-Rad company ownership details also shape how the brand is read by customers and investors. Founder continuity can signal that the business is still tied to its original mission, and that can help Bio-Rad ownership stay credible in evidence-driven markets. At the same time, the same structure can reduce outside pressure if strategic choices drift, because public Bio-Rad Laboratories investors do not have equal control.

For a deeper look at the operating side behind this structure, see the article on Revenue Streams & Business Model of Bio-Rad.

Bio-Rad Ansoff Matrix

• Structured to Support Better Decisions
• Effortlessly Communicate Your Business Strategy
• Investor-Ready Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Bio-Rad Laboratories has a board built for continuity, not rapid change. The current board works under a dual-class structure that keeps real control with the Schwartz family and limits how much Bio-Rad shareholders outside that block can force through.

Who owns Bio-Rad Laboratories is really a question about voting rights, not just share count. Bio-Rad ownership structure separates cash flow from control, so Bio-Rad stock ownership by public holders does not equal power. For a plain view of the company's roots, see Brief History of Bio-Rad.

Who controls Bio-Rad Laboratories

Bio-Rad founder family ownership still shapes the key votes. The board and executives matter, but the voting block sets the ceiling on outside pressure.

• Class B shares carry superior voting power
• Public holders have weaker proxy leverage
• Board committees still follow public-company rules
• Activist pressure has stayed limited

Bio-Rad Balanced Scorecard

• Clean, Modern, and Easy to Present
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

Bio-Rad ownership has stayed stable through 2025, with no takeover, privatization, or parent-company shift. The Bio-Rad ownership structure still centers on founder family control and dual-class voting shares, so the market sees continuity more than change.

Who owns Bio-Rad Laboratories is still mainly a control question, not a change story. Bio-Rad shareholders get public-market exposure, but Bio-Rad insider ownership and Bio-Rad voting shares keep decision power concentrated, which is why Bio-Rad institutional ownership does not translate into equal control. For a related view on brand identity, see Mission, Vision & Core Values of Bio-Rad.

Why credibility stays high

Bio-Rad family ownership signals patience. Customers in diagnostics and research tools often value stable ownership because product validation takes time.

Why governance risk remains

Bio-Rad company ownership details still point to concentrated power. That lowers equal-shareholder accountability even when operating results stay steady.

What has not changed

There has been no control transaction in the last 3 to 5 years. The Bio-Rad ownership breakdown has remained anchored in the same family-linked structure.

What investors should note

Bio-Rad largest shareholders matter less than voting power here. Bio-Rad stock ownership offers durability, but Bio-Rad stockholder information still reflects control concentration.

Bio-Rad VRIO Analysis

• Designed for Fast Business Analysis
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔